Medical Devices Group

  • Community
  • Webinars
  • Jobs
  • Events
  • Contact
  • Go Premium
« Back to Previous Page
like 4 comments  share
Steve Priolo
Director of Quality Assurance at MedAlliance LLC
November 2016
Question on the impact of MEDDEV 2.7.1- Rev. 4 on Clinical Evaluation Report Updates
< 1 min reading time

I understand the existing requirement for updating Clinical Evaluation Reports with respect to current safety and performance information. But, I was wondering if there is also an expectation to update Clinical Evaluation Reports with the other new requirements mentioned in the Rev. 4 MEDDEV document. As an example, would a CER performed using a prior MEDDEV version now have to be updated to include a specific identification of the “State of the Art” product(s)? In addition, would the CER author now be required to complete a “Statement of Interest”? Thank you in advance.

source: https://www.linkedin.com/groups/78665/78665-6202643771381944322

Marked as spam
Posted by Steve Priolo
Asked on November 11, 2016 12:00 am
118 views
  • Follow
  • Unfollow
  • Report spam
like 4 comments  share

Meet your next client here. Join our medical devices group community.

Private answer
Marcelo Antunes The requirement to keep clinical evaluation up-to-date to the state of the art is not new, although it was implicit in the past and it's now explicit in the new MEDDEV. But, as the essentials requirements of the MDD already required that the design has to be " taking account of the generally acknowledged state of the art, this already include clinical evaluation. So yes, any CER performed previously will have to incude this.

Please note that there is an expectation that all CERs are updated to the new expectations of Revision 4, anyway. So ALL CER's performed previously will have to include all new expectations of Rev 4.

Related to interest, the expectation is that all evaluators have a clear declaration of interests so it's clear that they are not under pressure to reach their conclusions.
Marked as spam
like
  • Report spam
Private answer
Daniel John Soon MDR will replace the EU’s current MDD (93/42/EEC) and the EU’s Directive on AIMD (90/385/EEC). Proposed MDR requires Identification of “qualified person” within the organization who is ultimately responsible for all aspects of compliance with the requirements of the new MDR. The organization must also document the specific qualifications of this individual relative to the required tasks. This "qualified person" could also double up as your CER author who has to complete a "Statement of Interest" in compliance with MEDDEV 2.7/1 rev. 4.
Marked as spam
like
  • Report spam
Private answer
Daniel John "New requirements" in MEDDEV 2.7/1 rev. 4 includes, (a) Qualifications of authors and evaluators & (b) Access to data for equivalent devices. Rest of the changes are "additional clarifications" to MEDDEV 2.7/1 rev. 3. But the implementation of MEDDEV 2.7/1 rev. 4 depends on the NB since the MEDDEV 2.7/1 rev. 4 is dated June 2016. I have recently (Jan to Nov. 2016) completed recertification of our 09 Class III devices and our NB did not insist compliance with MEDDEV 2.7/1 rev. 4. Probably rev 4. might come into effect along with MDR in 2017 with a three-year transition period for medical devices and five years for IVDs manufacturers.
Marked as spam
like
  • Report spam
Private answer
Hi Marcello,

BSI presented on MEDDEV 2.7.1 Rev 4, top 10 key changes. It also includes MDR relevant information.The webinar and presentation is available online. It's very useful and clearly sets out BSI transition expectations. Other NB's may operate differently.

Best of luck.
Marked as spam
like
  • Report spam
« Back to Previous Page
Ask a Question
Leave a Comment

We still use LinkedIn to access our site because it’s the only way to “pull in” your LinkedIn photo, name, and hyperlink to your profile page, all vital in building your professional network. When you log in using LinkedIn, you are giving LinkedIn your password, not me. I never see nor store your LinkedIn credentials.

Stay connected with us.

By signing up you are agreeing to our Privacy Policy.

Categories

  • Capital/Investment
    • Business Model
    • Funding
  • Careers
  • Design/Devel
    • Design
    • Development
    • Human Factors
    • Labeling
    • Material Selection
    • R&D
    • Trials and Post-Market
  • Featured
  • Industry
    • Announcements
    • Device Tax
    • Hospital and Health Care
    • Innovation
    • Medtech
  • LinkedIn, etc.
  • Markets
    • Africa
    • Americas
    • Asia
    • Australia
    • Europe
  • Regulating
    • CE Marking
    • EU
    • FDA
    • FDA/EU etc.
    • Notified Bodies
    • Quality
    • Regulatory
  • Selling
    • Distribution
    • Intellectual Property
    • Marketing/Sales
    • Reimbursement
  • Worth bookmarking!
Feature your job here.
logo

Companion to LinkedIn's 350,000 member community

  • Contact
  • Medical Device Marketing
  • In Memoriam
  • Medical Device Conference

The Medical Devices Group   |   Copyright © 2025 Terms, Conditions & Privacy

Medical Devices Group
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.